The liposome displays durable ability to target glioma cells and brain microvascular endothelial cells (BCECs) and to deliver drugs (PTX/siRNA) to CD133+ glioma stem cells, which exhibits great potential for targeted imaging and therapy of brain glioma stem cells. The gene discussed is PROM1; the disease is central nervous system cancer.